Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 1
1996 1
1998 2
1999 1
2000 5
2001 2
2002 5
2003 3
2004 3
2005 4
2006 5
2007 8
2008 20
2009 26
2010 37
2011 26
2012 18
2013 19
2014 14
2015 10
2016 8
2017 11
2018 9
2019 6
2020 4
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Tumor heterogeneity-driven individualized therapy.
Baltagiannis EG, Ziogas DE, Cho WC, Mitsis M, Roukos DH. Baltagiannis EG, et al. Among authors: roukos dh. Future Oncol. 2021 Jan;17(3):235-240. doi: 10.2217/fon-2020-0915. Epub 2020 Dec 11. Future Oncol. 2021. PMID: 33305621 No abstract available.
Precision in cancer pharmacogenomics.
Kyrochristos ID, Baltagiannis EG, Mitsis M, Roukos DH. Kyrochristos ID, et al. Among authors: roukos dh. Pharmacogenomics. 2020 Apr;21(5):311-316. doi: 10.2217/pgs-2020-0011. Epub 2020 Apr 3. Pharmacogenomics. 2020. PMID: 32242500 No abstract available.
Longitudinal ctDNA profiling in precision oncology and immunο-oncology.
Filis P, Kyrochristos I, Korakaki E, Baltagiannis EG, Thanos D, Roukos DH. Filis P, et al. Among authors: roukos dh. Drug Discov Today. 2023 Apr;28(4):103540. doi: 10.1016/j.drudis.2023.103540. Epub 2023 Feb 21. Drug Discov Today. 2023. PMID: 36822363 Review.
Precision in personalized prediction-based medicine.
Kyrochristos ID, Ziogas DE, Roukos DH. Kyrochristos ID, et al. Among authors: roukos dh. Per Med. 2018 Nov;15(6):467-470. doi: 10.2217/pme-2018-0079. Epub 2018 Nov 2. Per Med. 2018. PMID: 30387685 Review. No abstract available.
From personalized to precision cancer medicine.
Baltagiannis EG, Kyrochristos ID, Ziogas DE, Goussia A, Mitsis M, Roukos DH. Baltagiannis EG, et al. Among authors: roukos dh. Per Med. 2020 Jul 1;17(4):245-250. doi: 10.2217/pme-2020-0056. Epub 2020 Jun 26. Per Med. 2020. PMID: 32589113 No abstract available.
Precise predictive and therapeutic strategy for breast cancer.
Kyrochristos ID, Peristeri DV, Ziogas DE, Lykoudis EG, Roukos DH. Kyrochristos ID, et al. Among authors: roukos dh. Future Oncol. 2018 Aug;14(18):1777-1780. doi: 10.2217/fon-2018-0277. Epub 2018 May 30. Future Oncol. 2018. PMID: 29846090 Free article. No abstract available.
From standard to new genome-based therapy of gastric cancer.
Lianos GD, Mangano A, Cho WC, Roukos DH. Lianos GD, et al. Among authors: roukos dh. Expert Rev Gastroenterol Hepatol. 2015;9(8):1023-6. doi: 10.1586/17474124.2015.1060856. Epub 2015 Jun 24. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26108988 Review.
Application of microRNAs in diabetes mellitus.
Chen H, Lan HY, Roukos DH, Cho WC. Chen H, et al. Among authors: roukos dh. J Endocrinol. 2014 Jul;222(1):R1-R10. doi: 10.1530/JOE-13-0544. Epub 2014 Apr 29. J Endocrinol. 2014. PMID: 24781254 Review.
227 results